Identification of epigenetic interactions between microRNA and DNA methylation associated with polycystic ovarian syndrome.
Zhanrui MaoTing LiHui ZhaoYulan QinXuesong WangYani KangPublished in: Journal of human genetics (2020)
Aberration in microRNA expression or DNA methylation is a causal factor for polycystic ovarian syndrome. However, the epigenetic interactions between miRNA and DNA methylation remain unexplored in PCOS. We conducted a novel integrated analysis of RNA-seq, miRNA-seq, and methylated DNA-binding domain sequencing on ovarian granulosa cells to reveal the epigenetic interactions involved in the pathogenesis of PCOS. We identified 830 genes and 30 miRNAs that were expressed differently in PCOS, and seven miRNAs negatively regulated target mRNA expression. 130 miRNAs' promoters were significantly differently methylated, while 13 were associated with miRNA expression. Furthermore, the hypermethylation of miR-429, miR-141-3p, and miR-126-3p' promoter was found related to miRNA expression suppression and therefore their corresponding genes upregulation, including XIAP, BRD3, MAPK14, and SLC7A5. Our findings provide a novel insight in PCOS. The consequential reversal of genes silencing may participate in PCOS pathogenesis and served as potential molecular targets for PCOS.
Keyphrases
- dna methylation
- genome wide
- polycystic ovary syndrome
- poor prognosis
- rna seq
- single cell
- gene expression
- insulin resistance
- dna binding
- copy number
- long non coding rna
- cell proliferation
- transcription factor
- bioinformatics analysis
- signaling pathway
- binding protein
- induced apoptosis
- case report
- oxidative stress
- type diabetes
- skeletal muscle
- pi k akt
- cell death
- long noncoding rna
- endoplasmic reticulum stress